Investing Profile

Vikram Bajaj

InvestorVC
Managing Director at Foresite Capital
Photo of Vikram Bajaj, Managing Director at Foresite Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Foresite Capital Managing Director
$100K - $5.0M
$1.5M
11
$668M
CompanyStageDateRound SizeTotal Raised
Foresight Diagnostics
Series BJul 2024$33M
Series BApr 2023$59M
$110M
Co-investors: Shahram Seyedin-Noor (Civilization Ventures), Jim Tananbaum (Foresite Capital)
Spear Bio
Series AJul 2024$45M
$45M
Co-investors: David Singer (Maverick Capital)
Xaira Therapeutics
Series AApr 2024$1B
$1B
Co-investors: Scott Gottlieb (New Enterprise Associates (NEA)), Robert Nelsen (ARCH Venture Partners)
Alumis
Series CMar 2024$260M
Series AMay 2021$70M
$330M
Co-investors: Jim Tananbaum (Foresite Capital), Michael Rome (Foresite Capital), Richard Gaster (venBio)
Pleno
Series AOct 2022$40M
$40M
Co-investors: Andrew ElBardissi (Deerfield Management)
TenSixteen Bio
Series AJan 2022$40M
$40M
Co-investors: Krishna Yeshwant (GV (Google Ventures))
Interline Therapeutics
Series AMay 2021$60M
$60M
Co-investors: Jay Parrish (ARCH Venture Partners)
Tesseract Health
Series BApr 2021$80M
$80M
Co-investors: Jim Tananbaum (Foresite Capital)